Vetted Financial Modeling Professionals

“Venture investing/sourcing professional with experience at L'Attitude running high-volume founder sourcing across tools (Harmonic) and ecosystem channels (accelerators, hackathons, Discord, university labs). Demonstrated ability to turn cold outreach and early relationships into diligence and investment committee discussions, while maintaining a rigorous CRM-driven pipeline process and long-term founder nurturing through consistent value-add.”

“Former investment banker who built an AI hiring tech platform to automate early-stage undergraduate screening for investment banks, validated via discovery calls with heads of HR and tailored workflows to bank-specific recruiting needs. Strong 0-to-1 operator with a disciplined approach to problem selection, moat analysis, and lean go-to-market execution.”

“Investor/sourcer from Morgan Stanley Expansion Capital focused on vertical SaaS, with a structured system for high-volume founder outreach (30–50/week) and thesis-driven messaging. Has originated cold outbound conversations (e.g., Elevate, Rockbot) and owned end-to-end diligence work including SaaS metric analysis, operating model building, and internal decision memos/partner updates.”

“Operations/finance transformation leader with experience in large healthcare organizations (e.g., PacifiCare and KP), brought in to stabilize and modernize operating cadence during high-change periods. Known for applying lean/agile methods (value-stream mapping, 2-week sprints, kanban, RACI) to build KPI single-sources-of-truth and scalable analytics operating models, delivering 40%+ cycle-time/rework reductions and improved forecasting/decision velocity.”

“Portfolio manager and investment/product leader in sustainable equities who drives cross-functional delivery across CIO office, research, client communications, marketing, and compliance. Notably built a thematic product framework and compliance-approved pitch materials that cut bespoke strategy turnaround from 1–3 months to 1 week and improved mandate win-rate from 10% to ~33%.”

“Life sciences business development leader with experience as Head of Business Development at Praxis Precision Medicines, leveraging VC relationships to source value-accretive opportunities such as a partnership with Cerebral Therapeutics. Demonstrates a founder-oriented mindset and unusually rigorous biotech opportunity assessment, including nuanced evaluation of mechanism, preclinical data, and compounded biology/technology risk.”